Alfred DeMaria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alfred DeMaria has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
L Kunches
2 shared publicationsB Caldwell
1 shared publicationB Shea
1 shared publicationB Werner
1 shared publicationBetsey John
Bureau of Communicable Disease Control, Massachusetts Department of Public Health, State Laboratory Institute, Jamaica Plain, Massachusetts
1 shared publicationC Cohen
1 shared publication
Latest Publications
- 6 June 2017
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 166 (11) , 846-847
Hearing From the Silent Epidemic
- 6 June 2017
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 166 (11) , 846-847
Hearing From the Silent Epidemic
- Open Access
- 27 January 2017
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 66 (3) , 76-79
Cluster of an Unusual Amnestic Syndrome — Massachusetts, 2012–2016
In November 2015, a neurologist in the Boston, Massachusetts, area reported four cases of an uncommon amnestic syndrome involving acute and complete ischemia of both hippocampi, as identified by magnetic resonance imaging (MRI), to the Massachusetts Department of Public Health (MDPH) (1). A subsequent e-mail alert, generated by the Massachusetts Board of Registration in Medicine and sent to relevant medical specialists (including neurologists, neuroradiologists, and emergency physicians), resulted in the identification of 10 additional cases that had occurred during 2012-2016. All 14 patients (mean and median age = 35 years) had been evaluated at hospitals in eastern Massachusetts. Thirteen of the 14 patients underwent routine clinical toxicology screening at the time of initial evaluation; eight tested positive for opioids, two for cocaine, and two for benzodiazepines. Apart from sporadic cases (2-6), this combination of clinical and imaging findings has been reported rarely. The apparent temporospatial clustering, relatively young age at onset (19-52 years), and associated substance use among these patients should stimulate further case identification to determine whether these observations represent an emerging syndrome related to substance use or other causes (e.g., a toxic exposure).
- 27 January 2017
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 66 (3) , 76-79
Open AccessCluster of an Unusual Amnestic Syndrome — Massachusetts, 2012–2016
In November 2015, a neurologist in the Boston, Massachusetts, area reported four cases of an uncommon amnestic syndrome involving acute and complete ischemia of both hippocampi, as identified by magnetic resonance imaging (MRI), to the Massachusetts Department of Public Health (MDPH) (1). A subsequent e-mail alert, generated by the Massachusetts Board of Registration in Medicine and sent to relevant medical specialists (including neurologists, neuroradiologists, and emergency physicians), resulted in the identification of 10 additional cases that had occurred during 2012-2016. All 14 patients (mean and median age = 35 years) had been evaluated at hospitals in eastern Massachusetts. Thirteen of the 14 patients underwent routine clinical toxicology screening at the time of initial evaluation; eight tested positive for opioids, two for cocaine, and two for benzodiazepines. Apart from sporadic cases (2-6), this combination of clinical and imaging findings has been reported rarely. The apparent temporospatial clustering, relatively young age at onset (19-52 years), and associated substance use among these patients should stimulate further case identification to determine whether these observations represent an emerging syndrome related to substance use or other causes (e.g., a toxic exposure).
- Open Access
- 4 December 2012
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 157 (11) , 823-824
The Resurgence of West Nile Virus
- 4 December 2012
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 157 (11) , 823-824
Open AccessThe Resurgence of West Nile Virus
- Open Access
- 15 March 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (12) , 1736-1738
Editorial Commentary: Accounting for Pertussis
The resurgence of measles and pertussis in the United States [1, 2] is a reminder of the importance of maximum immunization coverage, even in a developed country with relatively high rates of childhood immunization. The exact parameters of herd immunity may not be established for some vaccine-preventable diseases, but maximal effective use of available vaccines provides population-level immunity to prevent or reduce transmission. Evidence-based strategies published by the Advisory Committee on Immunization Practices (ACIP) for improved control of pertussis promote effective use [3, 4]. Observation of vaccine effectiveness in routine clinical use provides insight that may not be available from clinical efficacy trials and may be used to inform recommendations.
- 15 March 2012
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (12) , 1736-1738
Open AccessEditorial Commentary: Accounting for Pertussis
The resurgence of measles and pertussis in the United States [1, 2] is a reminder of the importance of maximum immunization coverage, even in a developed country with relatively high rates of childhood immunization. The exact parameters of herd immunity may not be established for some vaccine-preventable diseases, but maximal effective use of available vaccines provides population-level immunity to prevent or reduce transmission. Evidence-based strategies published by the Advisory Committee on Immunization Practices (ACIP) for improved control of pertussis promote effective use [3, 4]. Observation of vaccine effectiveness in routine clinical use provides insight that may not be available from clinical efficacy trials and may be used to inform recommendations.
- 27 March 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (13) , 1413-1414
Book Review Infectious Disease Surveillance Edited by Nkuchia M. M'ikanatha, Ruth Lynfield, Chris A. Van Beneden, and Henriette de Valk. 538 pp., illustrated. Malden, MA, Blackwell, 2007. $169. 978-1-4051-4266-3
More than 100 years ago in London, William Farr plotted the geographic distribution of cholera deaths and John Snow surveyed his neighbors. Surveillance of infectious diseases has been, and continues to be, the most widely applied element of public health surveillance. The editors of Infectious Disease Surveillance note in their dedication that it is the “first critical step in protecting communities from infectious diseases.” Yet, as the authors of the book's chapter on the Epidemic Intelligence Service point out, public health surveillance is “an area not often covered in academic training.” Therefore, a survey of the surveillance of infectious diseases is a welcome addition.
- 27 March 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (13) , 1413-1414
Book Review Infectious Disease Surveillance Edited by Nkuchia M. M'ikanatha, Ruth Lynfield, Chris A. Van Beneden, and Henriette de Valk. 538 pp., illustrated. Malden, MA, Blackwell, 2007. $169. 978-1-4051-4266-3
More than 100 years ago in London, William Farr plotted the geographic distribution of cholera deaths and John Snow surveyed his neighbors. Surveillance of infectious diseases has been, and continues to be, the most widely applied element of public health surveillance. The editors of Infectious Disease Surveillance note in their dedication that it is the “first critical step in protecting communities from infectious diseases.” Yet, as the authors of the book's chapter on the Epidemic Intelligence Service point out, public health surveillance is “an area not often covered in academic training.” Therefore, a survey of the surveillance of infectious diseases is a welcome addition.
- Open Access
- 15 September 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (6) , 804-807
Challenges of Sexually Transmitted Disease Prevention and Control: No Magic Bullet, but Some Bullets Would Still Be Appreciated
Potential conflicts of interest. A.D.: no conflicts.
- 15 September 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (6) , 804-807
Open AccessChallenges of Sexually Transmitted Disease Prevention and Control: No Magic Bullet, but Some Bullets Would Still Be Appreciated
Potential conflicts of interest. A.D.: no conflicts.
- Open Access
- 15 September 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (6) , 829-833
Diagnostic Evaluation for Creutzfeldt-Jakob Disease in Massachusetts, 1991-2001
Background. Surveillance for Creutzfeldt-Jakob disease (CJD) in the United States has become a focus of public health attention due to concerns about
- 15 September 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (6) , 829-833
Open AccessDiagnostic Evaluation for Creutzfeldt-Jakob Disease in Massachusetts, 1991-2001
Background. Surveillance for Creutzfeldt-Jakob disease (CJD) in the United States has become a focus of public health attention due to concerns about
- Open Access
- 22 October 2001
- Published by Springer Nature in BMC Public Health
- Vol. 1 (1) , 1-9
Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection
Gaps in disease surveillance capacity, particularly for emerging infections and bioterrorist attack, highlight a need for efficient, real time identification of diseases. We studied automated records from 1996 through 1999 of approximately 250,000 health plan members in greater Boston. We identified 152,435 lower respiratory infection illness visits, comprising 106,670 episodes during 1,143,208 person-years. Three diagnoses, cough (ICD9CM 786.2), pneumonia not otherwise specified (ICD9CM 486) and acute bronchitis (ICD9CM 466.0) accounted for 91% of these visits, with expected age and sex distributions. Variation of weekly occurrences corresponded closely to national pneumonia and influenza mortality data. There was substantial variation in geographic location of the cases. This information complements existing surveillance programs by assessing the large majority of episodes of illness for which no etiologic agents are identified. Additional advantages include: a) sensitivity, uniformity and efficiency, since detection of events does not depend on clinicians' to actively report diagnoses, b) timeliness, the data are available within a day of the clinical event; and c) ease of integration into automated surveillance systems. These features facilitate early detection of conditions of public health importance, including regularly occurring events like seasonal respiratory illness, as well as unusual occurrences, such as a bioterrorist attack that first manifests as respiratory symptoms. These methods should also be applicable to other infectious and non-infectious conditions. Knowledge of disease patterns in real time may also help clinicians to manage patients, and assist health plan administrators in allocating resources efficiently.
- 22 October 2001
- Published by Springer Nature in BMC Public Health
- Vol. 1 (1) , 1-9
Open AccessUsing automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection
Gaps in disease surveillance capacity, particularly for emerging infections and bioterrorist attack, highlight a need for efficient, real time identification of diseases. We studied automated records from 1996 through 1999 of approximately 250,000 health plan members in greater Boston. We identified 152,435 lower respiratory infection illness visits, comprising 106,670 episodes during 1,143,208 person-years. Three diagnoses, cough (ICD9CM 786.2), pneumonia not otherwise specified (ICD9CM 486) and acute bronchitis (ICD9CM 466.0) accounted for 91% of these visits, with expected age and sex distributions. Variation of weekly occurrences corresponded closely to national pneumonia and influenza mortality data. There was substantial variation in geographic location of the cases. This information complements existing surveillance programs by assessing the large majority of episodes of illness for which no etiologic agents are identified. Additional advantages include: a) sensitivity, uniformity and efficiency, since detection of events does not depend on clinicians' to actively report diagnoses, b) timeliness, the data are available within a day of the clinical event; and c) ease of integration into automated surveillance systems. These features facilitate early detection of conditions of public health importance, including regularly occurring events like seasonal respiratory illness, as well as unusual occurrences, such as a bioterrorist attack that first manifests as respiratory symptoms. These methods should also be applicable to other infectious and non-infectious conditions. Knowledge of disease patterns in real time may also help clinicians to manage patients, and assist health plan administrators in allocating resources efficiently.
- 16 September 2000
- Vol. 3 (4) , 182-92
Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group.
To assess immunogenicity of recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccine (rgp160) in late HIV infection. HIV-infected volunteers (n = 142), with CD4+ T lymphocyte counts of or =4-fold increase) against one or more gpl60 epitopes (C1, V3, C41, 448C). Delayed-type hypersensitivity (DTH) to intradermal gpl60, initially not present in any participant, developed after immunization in 41%, with higher prevalence in participants receiving the lower dose of vaccine. Both antibody and skin test responses occurred in 20-25% of vaccine recipients. Virtually all antibody and skin test responses occurred in participants with initial CD4+ cell counts of >100 cells/mm3. IFN-gamma had no significant effect on immune response. Immunization was well tolerated. Trends in CD4+ cell count, clinical events, and laboratory findings correlated with baseline CD4+ T lymphocyte count stratum and not with immunization regimen. Opportunistic conditions occurred at expected rates. Viral load trends (p24 antigen in all participants and viral RNA by reverse transcription-polymerase chain reaction in a subset of 26 participants) did not correlate with immunization regimen. Immunization of patients with advanced HIV infection with rgpl60 resulted in new and augmented humoral and DTH responses, without unexpected significant adverse events or evident clinical benefits attributable to immunization.
- 16 September 2000
- Vol. 3 (4) , 182-92
Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group.
To assess immunogenicity of recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccine (rgp160) in late HIV infection. HIV-infected volunteers (n = 142), with CD4+ T lymphocyte counts of or =4-fold increase) against one or more gpl60 epitopes (C1, V3, C41, 448C). Delayed-type hypersensitivity (DTH) to intradermal gpl60, initially not present in any participant, developed after immunization in 41%, with higher prevalence in participants receiving the lower dose of vaccine. Both antibody and skin test responses occurred in 20-25% of vaccine recipients. Virtually all antibody and skin test responses occurred in participants with initial CD4+ cell counts of >100 cells/mm3. IFN-gamma had no significant effect on immune response. Immunization was well tolerated. Trends in CD4+ cell count, clinical events, and laboratory findings correlated with baseline CD4+ T lymphocyte count stratum and not with immunization regimen. Opportunistic conditions occurred at expected rates. Viral load trends (p24 antigen in all participants and viral RNA by reverse transcription-polymerase chain reaction in a subset of 26 participants) did not correlate with immunization regimen. Immunization of patients with advanced HIV infection with rgpl60 resulted in new and augmented humoral and DTH responses, without unexpected significant adverse events or evident clinical benefits attributable to immunization.
- 1 November 1992
- Vol. 11 (11) , 941-5
Perinatally acquired human immunodeficiency virus infection: extent of clinical recognition in a population-based cohort. Massachusetts Pediatric HIV Surveillance Working Group.
To evaluate factors that may affect the timely diagnosis of children with human immunodeficiency virus (HIV) infection, we compared data derived from two population-based pediatric HIV studies. Data from anonymous newborn HIV serosurveys were used to estimate the number of children born to HIV-seropositive mothers. A statewide active surveillance project determined the number of HIV-exposed children who had been clinically recognized. Of 88,732 Massachusetts newborn specimens tested anonymously for HIV antibodies during a 12-month period (November, 1987, to October, 1988), 223 were positive. As of October, 1991, 78 of these children (35%) had been identified by a statewide network of infectious disease physicians. HIV-exposed children born in inner city hospitals were more likely to have come to medical attention than those born in suburban hospitals (47% vs. 17%). Among the 29 children with confirmed HIV infection (13% of 223), the initial evaluation for HIV occurred at an earlier age among children born in inner city hospitals than among children born in other areas. HIV testing practices that rely heavily on risk assessment may result in delayed diagnosis of HIV infection in children whose mothers are not perceived to be at risk.
- 1 November 1992
- Vol. 11 (11) , 941-5
Perinatally acquired human immunodeficiency virus infection: extent of clinical recognition in a population-based cohort. Massachusetts Pediatric HIV Surveillance Working Group.
To evaluate factors that may affect the timely diagnosis of children with human immunodeficiency virus (HIV) infection, we compared data derived from two population-based pediatric HIV studies. Data from anonymous newborn HIV serosurveys were used to estimate the number of children born to HIV-seropositive mothers. A statewide active surveillance project determined the number of HIV-exposed children who had been clinically recognized. Of 88,732 Massachusetts newborn specimens tested anonymously for HIV antibodies during a 12-month period (November, 1987, to October, 1988), 223 were positive. As of October, 1991, 78 of these children (35%) had been identified by a statewide network of infectious disease physicians. HIV-exposed children born in inner city hospitals were more likely to have come to medical attention than those born in suburban hospitals (47% vs. 17%). Among the 29 children with confirmed HIV infection (13% of 223), the initial evaluation for HIV occurred at an earlier age among children born in inner city hospitals than among children born in other areas. HIV testing practices that rely heavily on risk assessment may result in delayed diagnosis of HIV infection in children whose mothers are not perceived to be at risk.